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Abstract: The structural diversity of oligosaccharides found in glycoconjugates is enormous. This is due to the number of different
ways in which sugar monomers may be linked to each other regarding linkage position, anomeric configuration, pyranosidic or
furanosidic ring form and chain branching. It has been proposed that these factors contribute to the exquisite potential of
oligosaccharides to establish a code system of biological information. The information contained in these structures is decoded by
complementary sites present on carbohydrate binding proteins (lectins).
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Hayat›n Üçüncü Alfabesi: Karbonhidrat-Protein Etkileflimleri
Özet: Glikokonjugatlar›n yap›s›nda bulunan oligosakkaritler büyük yap›sal farkl›l›klar gösterir. Bu farkl›l›k fleker monomerlerinin
aralar›nda oluflturduklar› ba¤lar›n çok de¤iflken olmas›ndan, anomerik konfirigasyon, piran ve furan halka yap›lar› ve dallanmalardan,
kaynaklan›r. Bu farkl› yap› sayesinde oligosakkaritlerin biyolojik enformasyon içeren bir kod sistemi oluflturdu¤u kabul edilmektedir.
Bu sistemde flifrelenmifl olan biyolojik bilgi, flekerlere spesifik proteinler (lektinler) taraf›ndan tan›nmaktad›r.
Anahtar Sözcükler: Biyolojik kod, karbonhidrat, lektin, farkl›laflma, geliflme

Introduction
th

For the first half of the 20 century proteins and
carbohydrates were considered separate classes of
natural products, and most chemists and biochemists had
little doubt about which of the 2 deserved their attention.
Such an attitude was based largely on the widely held
belief that carbohydrates are dull compounds and that
they serve only as structural or protective materials (e.g.,
cellulose in plants and chitin in insects) and as an energy
source (glycogen in animals), but lack any biological
specificity (1). However, there is increasing evidence,
formulated over 20 years ago, that carbohydrates act as
recognition determinants in a variety of physiological and
pathological processes (2-11). This concept evolved with
the realisation that carbohydrates have enormous
potential for encoding biological information (12,13).
The messages encoded in the structures of complex
carbohydrates are deciphered through interactions with
complementary sites on carbohydrate-binding proteins,
chiefly lectins (14). Processes in which the participation
of carbohydrate-lectin interactions was clearly
demonstrated include intracellular trafficking of enzymes,

clearance of glycoproteins from circular systems and a
wide range of cell-cell interactions (15-19).
Oligosaccharides occurring in biological systems are
often linked to lipids or proteins. The resultant
glycoconjugates encompass glycoproteins (including
proteoglycans), glycopeptides, peptidoglycans and glycolipids
as well as lipopolysaccharides. Glycoconjugates are found
inside the cells, both in the cytoplasm and subcellular
organelles, and within cell membranes as well as in
extracellular fluids and matrices (20). Furthermore,
oligosaccharides are integral parts of many important classes
of macromolecules, such as structural proteins, enzymes,
transport proteins, hormones, immunoglobulins, cell
adhesion molecules, toxins and lectins (20). The biological
functions of these sugar chains may include merely structural
effects by influencing and controlling the conformation and
stability of a protein, but also the modulation of the
functional activity of a protein, exposure of target structures
for toxins, antibodies and micro-organisms, masking of such
epitopes and the provision of ligands for specific binding
events that mediate cell-cell or cell-matrix interactions,
“
thereby intervening in the social life of cells” (20-22).
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Based on the nature of the linkage between their
polypeptide chains and their oligosaccharide chains
glycoproteins can be divided into 3 major classes: (1) Oglycans, involving the hydroxyl side chain of serine or
threonine and a sugar such as GalNAc, (2) N-glycans,
involving the amide nitrogen of asparagine and GlcNAc,
and (3) GPI anchor (GPI-anchored or GPI-linked). Those
linked to the carboxyterminal amino acid of a protein via
a phosphorylethanolamine moiety are joined to an
oligosaccharide, which in turn is linked via glucosamine to
phosphotidylinositol (23-25). There are considerable
differences in the number distribution of glycan chains
along the polypeptide backbone according to the
glycoprotein type. Generally N-linked glycoproteins
contain a few oligosaccharide chains (1 to 5), which are
separated by several amino acid residues, whereas Olinked glycoproteins contain a high number of chains in
close proximity that form clusters (26). In addition, some
glycoproteins
contain
both
N-and
O-linked
oligosaccharides.
Similar to glycoproteins, glycolipids also represent a
structural heterogeneous group of glycoconjugates found
in all living organisms ranging from bacteria to humans.
In animals and humans, glycosphingolipids prevail, in
which ceramide provides the lipid anchor (27). The
carbohydrate chains, usually containing glucose at their
reducing termini, are linked via an O-glycosidic bond.
The sugar code
Proteins, nucleic acids and glycoconjugates
(glycopoteins and glycolipids) are large molecules
essential to all living cells. While nucleic acids and proteins
are linear molecules in which the building blocks are
joined together by identical bonds (phosphodiester and
amide bonds, respectively), the glycan moieties of
glycoconjugates are usually branched and the
monosaccharide building blocks may be joined to one
another in many different linkages. This has important
implications for biosynthesis. In the case of proteins and
nucleic acids every new molecule is copied from a preexisting template molecule acting as a mould. Glycans
cannot be copied from a mould and are manufactured on
an assembly line in which individual components are
incorporated sequentially. The potential number of all
possible linear and branched isomers of small
oligosaccharides has recently been calculated to be much
larger than previous estimations. Seven structural
elements lead to a large number of isomers, including
788

multiple ring sites as points of glycosidic attachment, α/β
anomerity, pyranose/furanose configuration and
branching structure. For example, 3 different hexoses
may be linked to each other to form over 1000 different
trisaccharides (23,28-30).
Carbohydrate-protein interactions in development
Embryonic development is a carefully coordinated and
complex process with a genetically determined time
schedule in which considerable changes occur in cell
differentiation-related properties such as growth, cell
alignment, cell mobility and cell overlapping (2). The
mechanism by which embryo cells migrate and orient
themselves in a highly organised manner is among the
crucial problems of the biology of development.
Understanding the biological roles of the diverse
oligosaccharides of glycoproteins, proteoglycans and
glycolipids has been a major challenge in cell biology.
Work with monoclonal and polyclonal antibodies has
shown that there are great changes in the display of
oligosaccharides at the surface of cells during embryonal
development and differentiation (31-36). This suggested
that such oligosaccharides may be important as ligands in
macromolecular interactions that determine the way cells
migrate or respond to various microenvironments. The
recently gained access to transgenic animals with defined
defects in N-linked glycosylation has provided
experimental proof that complex-type oligosaccharides
are indeed required for viability in embryogenesis (17).
In a number of studies (37-41) investigators have
used specific oligosaccharide/lectin staining patterns in the
definition of the dynamics of tissue development in
various embryonic models. In all these studies, the
oligosaccharide is viewed as a surface ligand that signals
subsequent specific changes in cellular differentiation (i.e.
the development of tissue/organ-specific function)
through interaction with its specific lectin receptor.
Using a model of neurite outgrowth in the nasal
cavity, Puche et al. (42) showed that galectin-1 was
essential for appropriate topologically specific projections
in the olfactory buds. This is evidence that this galactosespecific endogenous lectin orchestrates the spatial
organisation of specific cellular subsets. The investigation
by Shuler (43) illustrates the need for spatial and
temporal integration of growth/differentiation functions
in craniofacial development.
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Carbohydrates in cancer
O- and N-glycan chains of glycoproteins, as well as the
level and the spectrum of glycoprotein expression, may be
altered in tumour cells. In general, N-glycans are often
highly branched and sialylated in cancer, while O-glycans
are often truncated and sialylated (44-46). Many of the
tissue and blood group antigens that can be detected with
antibodies have been found to change in cancer (47-50).
The increased number of branches in tumour cells
provides attachment sites for additional poly Nactetyllactosamine chains, sialic acid residues and other
determinants that may function in cell adhesion or other
biological processes and in the protection of the cancer
cell surface, promoting survival in the blood stream and
invasion of tissues (46,47).
Human colorectal polyps that tend to develop into
carcinomas and apparently benign polyps may exhibit
changed carbohydrate activities (51,52). For example,
x
there may be an increase in sialyl-Le as well as an
y
x
appearance of extended Le and Le antigens during the
development to cancer and this may be correlated with
the malignant potential of polyps (53,54). Colon cancer
tissue produces glycoproteins and mucins with abnormal
glycosylation patterns that may resemble foetal patterns
(55,56). In addition, the genes encoding the peptide
moieties of glycoproteins and mucins may undergo
alterations of expression in colon cancer. These events
may be related to malignant potential and development of
the tumour; the mechanism inducing these changes is still
not understood (47).
Recent studies have indicated that overexpression of
galectin genes may occur in neoplastic cells and may be
correlated with tumor progression (57,58). The
expression of galectins on vascular endothelial cells
suggests that they are involved in the adhesion and
invasion of tumour cells. In vitro, antibodies against
galectin-1 inhibit the adhesion of lymphoma cells to
human microvascular endothelial cells (59).
Carbohydrate-mediated drug targeting
Targeted drug delivery involves the design and
synthesis of carriers displaying ligands that mediate the

binding of a drug/carrier complex to a receptor (60).
Subsequent internalisation of the carrier/drug complex
leads to accumulation of the drug in the target cells
and exclusion from non-target cells that lack the
requisite receptor (61,62). Site-specific drug or gene
delivery to diseased cells may be accomplished utilising
oligosaccharides that are recognised by membrane
lectins (62-65). Examples include liver parenchyma
asialo-receptors that recognise terminal galactose
residues, Kuppfer and liver endothelial cells that
recognise 4-sulphated GlcNAc residues and a variety of
cells that express mannose-6-phosphate receptors. The
drug carriers may be glycoproteins such as asialofetuin
or lactosaminated albumin. It is presumed that the
ligand-receptor complex will be actively endocytosed
and the drug made available at cellular target sites
(47). Targeted drug delivery needs to be a built-in
mechanism that causes intracellular liberation of the
drug from the carrier. To achieve this, drugs have been
linked to carriers via acid-label linkers that are cleaved
following endocytosis (66,67). Linkers that are stable
in the circulation but are degraded by proteases
present in lysosomes have also been developed (6871).

Conclusion
Research on biological roles of glycoconjugates has
made impressive progress in recent years. This has left
footprints in virtually all fields of biology and medicine.
Technical advances in oligosaccharide synthesis,
purification and structural analysis, together with the
steadily growing knowledge about endogenous binding
partners such as lectins, have enabled research activities
in the different areas of glycosciences to exert an obvious
influence on various disciplines in basic and applied
sciences. In view of ample documentation of carbohydrate
expression in animal tissues it is no longer appropriate to
consider trying to find out the biological roles of
carbohydrates as a bashful search for any tenuous thread
of evidence for a physiological relevance.
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